Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis
NCT00515450
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Generalized Myasthenia Gravis
Interventions
BIOLOGICAL:
GB-0998 (Intravenous immunoglobulin)
PROCEDURE:
Plasmapheresis
Sponsor
Benesis Corporation